Jennifer A. Webb
The FDA has cleared for marketing a hand-held spectral-domain ophthalmic imaging system that opens new doors to ophthalmologists to diagnose eye disease in infants, children, and disabled adults.
A record number of ophthalmologists hit the hallways on Capitol Hill last month to urge their legislators to protect Americans' access to eye care and boost funding for eye research.
Ophthalmologists should not order routine genetic tests for patients with common disorders like age-related macular degeneration until there are specific therapeutic interventions available to treat the disease based on the genetic information.
Having the ARVO meeting in any of various locations enables the group to accommodate more program options and have a variety of hotel options nearby.
FDA investigators say counterfeit vials of Roche/Genentech's bevacizumab that have turned up in U.S. medical practices for the second time in 2 months have no active ingredient.
Six years after OSI Pharmaceuticals Inc. bought Eyetech Pharmaceuticals Inc. for $650 million on the promise of its treatment for wet age-related macular degeneration, Valeant Pharmaceuticals International Inc. has announced it will acquire Eyetech for $22 million.
ISTA Pharmaceuticals says it is discussing a potential sale with a number of buyers, as Canada's biggest drug maker presses the board to accept its $360 million takeover bid.
Hansjoerg E.J.W. Kolder, MD, PhD, will e remembered as a beloved cataract surgeon, professor, and clinician whose natural curiosity led him to pursue a degree in ophthalmology after working extensively in physiology.
Legislators will try to sort out a fair compensation system for physicians after they staved off a scheduled 27.4% pay cut for those who treat Medicare patients.